{
  "dataStructureVersion": "2.0",
  "lastUpdated": "2015-03-13T21:07:00.065Z",
  "diseases": [
    {
      "valid": {
        "start": 2010
      },
      "primary_site_text": "Most common sites of involvement: lymph nodes, mediastinal mass, nasopharynx, tongue, stomach, bone and soft tissues. ",
      "treatment": [
        {
          "value": "Chemotherapy"
        }
      ],
      "missing_primary_site_message": [
        {
          "value": "See Module 7"
        }
      ],
      "icdO3_morphology": "9737/3",
      "first_published": "2013-07-29T20:24:12.546Z",
      "alternate_name": [
        {
          "value": "ALK-positive LBCL"
        },
        {
          "value": "ALK-positive plasmablastic B-cell lymphoma"
        },
        {
          "value": "Large B-cell lymphoma expressing the ALK kinase and lacking the t(2;5) translocation"
        }
      ],
      "type": "HEMATO",
      "diagnosis_method": [
        {
          "value": "Genetic testing"
        },
        {
          "value": "Histologic confirmation"
        },
        {
          "value": "Immunophenotyping"
        },
        {
          "value": "Karyotyping"
        }
      ],
      "version": "latest",
      "id": "51f6cf56e3e27c3994bd5306",
      "last_modified": "2015-01-28T14:51:55.812Z",
      "icd_10_code": [
        "C83.3 Diffuse non-Hodgkins lymphoma, large cell (diffuse)"
      ],
      "name": "ALK-positive large B-cell lymphoma",
      "grade": [
        {
          "value": 6
        }
      ],
      "abstractor_note": [
        {
          "value": "(This code is effective for cases diagnosed 2010 and later. For cases diagnosed prior to 2010, see code 9684/3.) \n\nMost patients present with Stage III/IV. Because these tumors are negative for CD20 antigen, they are insensitive to rituximab."
        }
      ],
      "same_primary": [
        {
          "value": "51f6cf58e3e27c3994bd53e4",
          "start": 2010
        }
      ],
      "signs": [
        {
          "value": "Drenching night sweats"
        },
        {
          "value": "Fatigue"
        },
        {
          "value": "Fever (for no known reason)"
        },
        {
          "value": "Painless swelling in the lymph nodes"
        },
        {
          "value": "Skin rash or itchy skin"
        },
        {
          "value": "Weight loss (for no known reason)"
        }
      ],
      "icd_9_code": [
        "200.6 Anaplastic large cell lymphoma"
      ],
      "icd_10cm_code": [
        {
          "value": "C84.6 Anaplastic large cell lymphoma, ALK positive"
        }
      ],
      "definition": [
        {
          "value": "This is a neoplasm of ALK-positive monomorphic large immunoblast-like B cells, sometimes with plasmablastic differentiation. This lymphoma is very rare (<1% of DLBCL) with less than 40 cases reported to date."
        }
      ],
      "immunophenotype": [
        {
          "value": "ALK-positive"
        },
        {
          "value": "CD3-"
        },
        {
          "value": "CD20-"
        },
        {
          "value": "CD30-"
        },
        {
          "value": "CD45-"
        },
        {
          "value": "CD79a-"
        },
        {
          "value": "CD138+"
        },
        {
          "value": "EMA"
        },
        {
          "value": "VS38+"
        }
      ],
      "reportable": [
        {
          "start": 2010
        }
      ],
      "genetics": [
        {
          "value": "CLTC-ALK fusion gene"
        },
        {
          "value": "Immunoglobulin genes are clonally rearranged"
        },
        {
          "value": "t(2;17)(p23;q23)"
        }
      ],
      "mortality": [
        {
          "value": "Age: 36 years median age (9-70 years range)"
        },
        {
          "value": "Incidence: <1% of DLBCL lymphomas"
        },
        {
          "value": "Sex: male predominance"
        },
        {
          "value": "Survival: median survival 11 months; >156 months survival for children"
        }
      ],
      "icdO3_effective": {
        "start": 2010
      },
      "exams": [
        {
          "value": "Blood chemistry studies"
        },
        {
          "value": "Bone marrow aspiration and biopsy"
        },
        {
          "value": "Immunohistochemistry"
        },
        {
          "value": "PET (positron emission tomography) scan"
        },
        {
          "value": "Physical exam and history (H&P)"
        }
      ]
    },
    {
      "icdO2_effective": {
        "start": 1992,
        "end": 2000
      },
      "valid": {
        "start": 2001
      },
      "primary_site_text": "Primary site must be bone marrow (C421)",
      "icdO1_morphology": [
        "9870/3",
        "1234/3"
      ],
      "treatment": [
        {
          "value": "Chemotherapy"
        },
        {
          "value": "Stem cell transplant"
        }
      ],
      "icdO2_morphology": [
        "9870/3"
      ],
      "icdO3_morphology": "9870/3",
      "first_published": "2013-07-29T20:24:12.546Z",
      "icdO1_effective": {
        "start": 1978,
        "end": 1991
      },
      "type": "HEMATO",
      "diagnosis_method": [
        {
          "start": 2010,
          "value": "Bone marrow biopsy"
        },
        {
          "start": 2010,
          "value": "Immunophenotyping"
        },
        {
          "start": 2010,
          "value": "Peripheral blood smear"
        }
      ],
      "version": "latest",
      "id": "51f6cf58e3e27c3994bd53e4",
      "last_modified": "2015-01-14T20:54:20.717Z",
      "icd_10_code": [
        "C92.1 Chronic myeloid leukemia"
      ],
      "name": "Acute basophilic leukemia",
      "abstractor_note": [
        {
          "value": "Cutaneous involvement, organomegaly, lytic lesion, and symptoms relating to hyperhistaminemia may be present.  Basophilic leukemia is differentiated from other AML subtypes with basophilia using basophilia immunological markers, light microscopic cytochemistry for myeloperoxidase and electron microscopy.\n\nIf the leukemia occurs before or simultaneously with Myeloid Sarcoma (9930/3), see M3 and Module 5: PH10"
        }
      ],
      "signs": [
        {
          "value": "Bone marrow failure"
        },
        {
          "value": "Cutaneous involvement"
        },
        {
          "value": "Easy bruising or bleeding"
        },
        {
          "value": "Petechiae"
        },
        {
          "value": "Shortness of breath"
        },
        {
          "value": "Weakness"
        },
        {
          "value": "Weight loss or loss of appetite"
        }
      ],
      "same_primary": [
        {
          "start": 2010,
          "value": "51f6cf56e3e27c3994bd5306"
        },
        {
          "value": "51f6cf58e3e27c3994bd53fc",
          "end": 2009
        },
        {
          "value": "51f6cf59e3e27c3994bd5432",
          "end": 2009
        },
        {
          "value": "51f6cf59e3e27c3994bd5435",
          "end": 2009
        }
      ],
      "icd_9_code": [
        "205.1 Chronic myeloid leukemia"
      ],
      "icd_10cm_code": [
        {
          "value": "C94.8 Other specified leukemias"
        }
      ],
      "definition": [
        {
          "value": "An acute myeloid leukemia in which the primary differentiation is to basophils.\n\nRare form of acute myeloid leukemia where blasts are accompanied by abnormal basophils in all stages of differentiation."
        }
      ],
      "immunophenotype": [
        {
          "start": 2010,
          "value": "CD11b+"
        },
        {
          "start": 2010,
          "value": "CD117-"
        },
        {
          "start": 2010,
          "value": "CD123+"
        },
        {
          "start": 2010,
          "value": "CD203c+"
        },
        {
          "start": 2010,
          "value": "HLA-DR+ (possible)"
        },
        {
          "start": 2010,
          "value": "TdT+ (possible)"
        }
      ],
      "reportable": [
        {
          "start": 1978
        }
      ],
      "primary_site": [
        {
          "high": "C421",
          "low": "C421"
        }
      ],
      "mortality": [
        {
          "value": "Incidence: <1% of all AML cases"
        },
        {
          "value": "Survival: limited information, known cases had poor prognosis"
        }
      ],
      "icdO3_effective": {
        "start": 2001
      },
      "exams": [
        {
          "value": "Bone marrow aspiration and biopsy"
        },
        {
          "value": "Complete blood count (CBC)"
        },
        {
          "value": "Peripheral blood smear"
        },
        {
          "value": "Physical exam and history"
        },
        {
          "value": "Reverse transcription-polymerase chain reaction test (RT-PCR)"
        }
      ]
    },
    {
      "same_primary": [
        {
          "value": "51f6cf56e3e27c3994bd5307",
          "end": 2008
        }
      ],
      "valid": {
        "start": 2001,
        "end": 2009
      },
      "icd_9_code": [
        "208.0 Acute leukemia of unspecified cell type"
      ],
      "definition": [
        {
          "value": "ABL can arise de novo OR secondary to previous cytotoxic therapy.\n\nFor diagnosis of leukemia where the lineage is of both lymphoid and myeloid origin.\n\nAcute leukemias of ambiguous lineage; the morphologic, cytochemical and immuno-phenotypic features of the proliferating blasts lack sufficient evidence to classify as myeloid or lymphoid origin (acute undiff leuk 9801/3) OR have morphologic and/or immunophenotypic characteristics of both myeloid and lymphoid cells or both B and T lineages."
        }
      ],
      "icd_10cm_code": [
        {
          "value": "C95.0 Acute leukemia of unspecified cell type",
          "start": "2014-01-01",
          "end": "2015-12-31"
        }
      ],
      "treatment": [
        {
          "value": "Bone marrow transplant"
        },
        {
          "value": "Chemotherapy"
        }
      ],
      "icdO3_morphology": "9805/3",
      "first_published": "2013-07-29T20:24:12.546Z",
      "alternate_name": [
        {
          "value": "Acute bilineal leukemia"
        },
        {
          "value": "Lineage infidelity"
        },
        {
          "value": "Lineage switches"
        }
      ],
      "reportable": [
        {
          "start": 2001,
          "end": 2009
        }
      ],
      "type": "HEMATO",
      "version": "latest",
      "primary_site": [
        {
          "high": "C421",
          "low": "C421"
        }
      ],
      "id": "51f6cf59e3e27c3994bd543e",
      "obsolete_new_code": [
        "51f6cf59e3e27c3994bd5459",
        "51f6cf59e3e27c3994bd546e",
        "51f6cf59e3e27c3994bd5474",
        "51f6cf59e3e27c3994bd5462"
      ],
      "last_modified": "2015-01-14T20:54:20.717Z",
      "icd_10_code": [
        "C95.0 Acute leukemia of unspecified cell type"
      ],
      "name": "Acute biphenotypic leukemia with",
      "grade": [
        {
          "value": 9,
          "start": 2005
        },
        {
          "value": 5,
          "end": 2004
        }
      ],
      "icdO3_effective": {
        "start": 2001,
        "end": 2009
      },
      "abstractor_note": [
        {
          "value": "This code may be used for cases diagnosed prior to 1/1/2010.\n\nThe term acute biphenotypic leukemia is not classified in WHO. There are several leukemias of ambiguous lineage, acute undifferentiated leukemia, mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1, mixed phenotype acute leukemia with t(v;11q23);MLL rearranged, mixed phenotype acute leukemia, B/myeloid , NOS, mixed phenotype acute leukemia, T/myeloid, NOS. Current cases will be coded to one of these neoplasms. For further information on the coding and abstracting of this disease, see histology codes 9806-9809. For an acute biphenotypic leukemia, NOS, see code 9809/3."
        }
      ]
    }
  ]
}